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INTRODUCTION
Cystitis glandularis (CG) is a proliferative and 
metaplastic disorder of the bladder urothelium1 that usually 
occurs when the bladder mucosa becomes hyperproliferative 
in the presence of chronic inflammation and nests of 
urothelium appear within the lamina propria. If inflammation 
persists, the urothelium may differentiate and eventually 
develop into cystic lesions (cystitis cystica) or glandular 
metaplastic lesions (cystitis glandularis).2 
CG is rarely reported in children; even in adults, its 
incidence and clinical significance are not well known.3 It 
is generally a microscopic finding subsequent to cystoscopy 
and biopsy in a patient with irritative bladder symptoms or 
hematuria.4-6 Most patients do not require more aggressive 
surgery options, and sparse literature is available regarding 
the management of severe CG.6 We report here a case of an 
AIDS (Acquired Immunodeficiency Syndrome) patient with 
cystitis glandularis refractory to standard treatment who was 
treated with a total cystoprostatectomy and ileal neobladder 
reconstruction.
CASE REPORT
A 47-year-old man presented at our institution with a 10-
year history of irritative and obstructive voiding symptoms 
and intermittent macroscopic hematuria. He was using 
Lamivudine, Zidovudine, and Efavirenz for treatment of 
acquired immune deficiency syndrome (AIDS). Physical 
examination revealed that he had a homogeneous 20 g 
prostate, and laboratory testing showed normal creatinine 
(1.2 mg/dL) and PSA (0.8 mg/dL). Urinary culture was 
invariably negative.
Urinary ultrasonography revealed a thickened bladder 
wall and a polypoid mass in the vesical trigone and prostatic 
urethra. Intravenous urography showed severe bilateral 
hydronephrosis and delayed contrast excretion (Figure 1). 
Computed tomography (CT) confirmed the thickening of the 
bladder wall and revealed bilateral distal ureteral thickening 
Figure 1 – Intravenous urography showing bilateral ureterohydronephrosis 
and delayed contrast excretion. (150 minutes)
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and dilatation up to the ureterovesical junction (Figure 2). 
Cystoscopy revealed a polypoid mass in the vesical trigone 
and prostatic urethra with an inflammatory aspect. The 
ureteral orifices were completely obstructed and therefore 
impossible to identify. An incomplete transurethral resection 
(TURB) of the lesion was performed. Histological study 
revealed chronic CG with the formation of an inflammatory 
polyp. 
After treatment, the patient was asymptomatic for 
two months, after which the irritative voiding symptoms 
recurred. Another two TURBs were performed, with partial 
and temporary improvement of the symptoms. Six months 
after the first TURB, the patient presented anuria and 
azotemia secondary to bilateral ureteral obstruction. Bilateral 
percutaneous nephrostomy was performed, with complete 
recovery of renal function. After considerable counseling, 
the patient underwent a total cystoprostatectomy with ileal 
neobladder construction. Microscopic analysis confirmed 
chronic CG all along the bladder urothelium (Figure 3). The 
postoperative period was uneventful. At the 6-month follow-
up, the patient was voiding well with complete continence; 
the serum creatinine level was 1.0 mg/dl and intravenous 
urography showed normal contrast excretion, with markedly 
reduced ureterohydronephrosis (Figure 4).
DISCUSSION
CG is a benign proliferative disease of the bladder 
mucosa. It is accepted that the intestinal metaplasia of 
cystitis glandularis is a result of a chronic irritative and 
infectious stimulus, initially appearing as submucosal masses 
of epithelial cells (Brunn’s nest) followed by cavitations of 
such structures, central necrosis, or serosal secretion. This 
results in the appearance of miliary cystic structures lined 
with cubic or columnar epithelium and filled with serosal 
fluid, termed cystitis cystica. The condition is termed cystitis 
glandularis when there is metaplasia in a mucus-secreting 
epithelium.7 
The exact incidence of cystitis glandularis is unknown. 
Patients with bladder exstrophy,8 pelvic lipomatosis9, and 
chronic or recurrent UTIs are considered to be at risk.7,10,11 
Other causal factors, such as avitaminosis, allergy, hormone 
Figure 2 –Pelvic computed tomography revealing diffuse bladder wall 
thickening and bilateral ureteral wall thickening and dilatation
Figure 3 - Histology showing glandular structures lined with mucus-secreting 
cubic and columnar cells consistent with cystitis glandularis
Figure 4- Intravenous urography, at the 6-month follow-up, showing normal 
contrast excretion and marked reduction of ureterohydronephrosis
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imbalance, specific carcinogens, and IgA-mediated immune 
mechanisms have been proposed.9,10 To our knowledge, 
our case is the first report of severe cystitis glandularis in 
a patient with AIDS. The exact correlation, if one exists, 
between immunodeficiency and cystitis glandularis is still 
unclear. 
If an etiology such as chronic infection is identified, it 
must be appropriately treated. In the reported case, no urinary 
infection or other causal factors were found. An associated 
risk of bladder cell carcinoma10 and adenocarcinoma has 
been reported11-15 but is still debated.4 Although most patients 
with cystitis glandularis will never develop a malignant 
bladder lesion, it cannot be excluded that the most widely 
proliferative lesions may have premalignant potential.7 
Lesions of cystitis glandularis are most frequent at 
the bladder neck or trigone,3 as in the reported case. If 
a mass lesion is identified, it is resected transurethrally. 
Generally, effective management is implemented and no 
further procedures are necessary to control the disease. 
Intravesical BCG (bacillus Calmette-Guerin) application 
has been described as an adjuvant therapy after TURB for 
the treatment of cystitis glandularis.16 Ureteral obstruction 
is a rare complication that results from infiltration of the 
periureteral submucosa.17 It may be treated with ureteral 
reimplantation into the dome of the bladder18 in the 
presence of a contractile bladder, or may require temporary 
percutaneous nephrostomy, as was performed in our patient. 
Intravesical hydrocortisone instillation19 and laser ablation20 
for the management of severe CG cases have been reported 
as alternative treatments. Cystectomy with continent urinary 
diversion for cystitis glandularis has been very rarely 
reported.6,5 Obviously, such surgical procedures should be 
the last resort in these patients.6 Urinary diversion without 
cystectomy in such cases is considered to be ill-advised due 
to the possibility of persistent symptoms and the associated 
risk of adenocarcinoma. Our current patient had florid 
disease, leading to persistent irritative voiding symptoms 
and upper urinary tract obstruction even after multiple 
transurethral resections. He was successfully submitted to 
cystoprostatectomy with ileal neobladder reconstruction and 
has been asymptomatic up to the present.
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